Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care

Lancet

Volumn 356, Issue 9246, 2000, Pages 1965-1969

  Delaney, B C ^a   Wilson, S ^a   Roalfe, A ^a   Roberts, L ^a   Redman, V ^a   Wearn, A ^a   Briggs, A ^b   Hobbs, F D R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; FEMALE; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0034627196     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03308-0     Document Type: Article

References (30)

1. Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: An economic evaluation based on a randomized trial
2. Dyspepsia and dyspepsia subgroups: A population-based study
3. Current European concepts in the management of Helicobacter pylori infection: The Maastricht consensus report
4. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
5. What happens to patients with non-ulcer dyspepsia after endoscopy
6. What happens to patients following open access gastroscopy? An outcome study from general practice
7. Guidelines on appropriate indications for upper gastrointestinal endoscopy
8. Endoscopy vs H2 blockers in management of dyspepsia
9. Early detection of gastric cancer
10. Management of dyspepsia: Report of a working party
11. Functional dyspepsia: A classification with guidelines for diagnosis and management
12. Management of dyspeptic patients in primary care - Value of the unaided clinical diagnosis and of dyspepsia subgrouping
13. Effect of Helicobacter pylori eradication therapy on dyspeptic symptoms in primary care
14. Quality of life in duodenal ulcer disease
15. Characteristics of practices, general practitioners and patients related to levels of patients' satisfaction with consultations
16. Ratio-based and net benefit-based approaches to health care resource allocation: Proofs of optimality and equivalence
17. Handling uncertainty when performing economic evaluation of healthcare interventions
18. Confidence intervals or surfaces? Uncertainty of the coat effectiveness plane
19. Randomised controlled trials in primary care: Case study
20. Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine
21. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease
22. Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters
23. Trying to do better than average: A commentary on 'statistical inference for cost-effectiveness ratios'
24. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
25. Cost effectiveness of omeprazole in the treatment of reflux oesophagitis
26. Evaluation of the dyspeptic patient: A cost-utility study
27. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
28. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences